Novozymes A/S (OTCMKTS:NVZMY) Stock Price Passes Above 50-Day Moving Average – What’s Next?

Novozymes A/S (OTCMKTS:NVZMY)’s stock price passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $63.19 and traded as high as $65.40. Novozymes A/S shares last traded at $64.96, with a volume of 43,203 shares traded.

Novozymes A/S Trading Down 0.1%

The firm has a market capitalization of $30.04 billion, a P/E ratio of 37.92, a PEG ratio of 1.18 and a beta of 1.09. The business’s 50 day moving average is $63.12 and its two-hundred day moving average is $63.91. The company has a quick ratio of 1.00, a current ratio of 1.61 and a debt-to-equity ratio of 0.26.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).